Web Analytics
 

2002: LYMErix pulled off the market via FDA ultimatum.

 

In the end, the FDA gave SmithKline an ultimatum- either take LYMErix off the market or they would.  To this day they still claim it was due to low sales.  If sales were plummeting, it was thanks to word getting out that the vaccine was making people sick.